Pfizer will continue the antitrust lawsuits.

Pfizer Inc. (PFE) announced on Wednesday evening that it will continue its legal and antitrust claims. During this process, the company will focus on factors affecting market conditions and the competitive environment while pursuing its ongoing legal battles.

Within the framework of its growth strategies, Pfizer will intensify its efforts to maintain and enhance its market share. In particular, it is demonstrating determination in accelerating and effectively managing legal processes. The outcomes of the related lawsuits could significantly impact the company’s financial performance and overall market dynamics.